EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Half-Dose versus Full Dose of Aprotinin in Cardiac Surgery: A Post-hoc Analysis of the Aprotinin European Registry

Pascal H Colson iD, Baptiste Gaudriot iD, Sophie Provenchère iD, Bertrand Rozec iD, Bernard Cholley iD, Philippe Mauriat iD, Marc Sénard iD, Jean-Luc Fellahi iD, NAPaR (Nordic Aprotinin Patient Registry) Investigators

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf260 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Pascal H Colson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Département d'anesthésie-réanimation, CHU Montpellier, Avenue Doyen Giraud, Montpellier, 34295, France. Hauptthemen laut MEDLINE: Aprotinin, Cardiac Surgical Procedures. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nordic Pharma B.V.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare the effectiveness and safety of the full and half doses of aprotinin, using the extended version of the Nordic Aprotinin Patient Registry, which was imposed by the European Medicines Agency following the reintroduction of aprotinin in cardiac surgery in the European market.

Methods

A post-hoc analysis was performed on data prospectively collected from adult patients exposed to aprotinin during cardiac surgery, in 83 cardiovascular surgical centres in 9 European countries, from February 26, 2016 to October 5, 2022. Full-dose (FD) and half-dose (HD) regimens were used at the surgical team’s discretion. The FD loading, priming, and infusion doses were 2 MKIU, 2 MKIU, and 0.5 MKIU/h, respectively. Incidence of re-exploration for bleeding/tamponade 2 days after surgery (2 D-re-exploration), 7 D-mortality, 3 D-MACCE (major adverse cardiac and cerebral events), and 1 D-AKI (acute kidney injury) were compared between FD and HD patients using propensity score methods to reduce confounders.

Results

A total of 2961 (44.4%) patients received the FD regimen and 3703 (55.6%) the HD regimen. After adjustment, the incidence of 2 D-re-exploration was estimated at 3.2% in the FD group and 4.4% in the HD group: OR [95% CI] = 0.70 [0.53-0.94] (P = .015). No difference in 7 D-mortality or 3 D-MACCE was observed between the 2 regimens. The incidence of 1 D-AKI was higher in patients with pre-operative renal dysfunction who received the FD regimen.

Conclusions

Patients receiving the FD aprotinin regimen had less surgical re-exploration than those receiving the HD regimen. An increased risk of early postoperative AKI was observed in the FD group, mainly for patients with pre-operative chronic kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AprotininCardiac Surgical ProceduresHumansRegistriesMaleFemaleEuropeAgedMiddle AgedHemostaticsProspective StudiesDose-Response Relationship, Drug

Stichwörter der Autor:innen

aprotinincardiac surgerypostoperative bleedingregistries

Substanzen

AprotininHemostatics

Autor:innen und Institutionen

  • Département d'anesthésie-réanimation, CHU Montpellier, Avenue Doyen Giraud, Montpellier, 34295, France.
  • CHU Rennes, 2 rue Henri-Le-Guilloux, Rennes, 35000, France.
  • AP-HP, Bichat-Claude Bernard Hospital, 46 Rue Henri Huchard, Paris, 75018, France.
  • CHU Nantes, Boulevard Jacques Monod, Nantes, 44000, France.
  • Service d'Anesthésie-Réanimation, Hôpital Européen Georges Pompidou, AP-HP, 20 rue Leblanc, Paris, 75015, France.
  • CHU Bordeaux, 1 Avenue de Magellsn, Bordeaux, 33600, France.

ORCID-Profile: Pascal H Colson, Baptiste Gaudriot, Sophie Provenchère, Bertrand Rozec, Bernard Cholley, Philippe Mauriat, Marc Sénard, Jean-Luc Fellahi

Förderung

  • Nordic Pharma B.V

Zitieren

APA

Colson, P. H., Gaudriot, B., Provenchère, S., Rozec, B., Cholley, B., Mauriat, P., Sénard, M., Fellahi, J. L., & NAPaR (Nordic Aprotinin Patient Registry) Investigators (2025). Half-Dose versus Full Dose of Aprotinin in Cardiac Surgery: A Post-hoc Analysis of the Aprotinin European Registry. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf260

Vancouver

Colson PH, Gaudriot B, Provenchère S, Rozec B, Cholley B, Mauriat P, et al. Half-Dose versus Full Dose of Aprotinin in Cardiac Surgery: A Post-hoc Analysis of the Aprotinin European Registry. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf260

BibTeX
@article{Colson2025,
  author = {Colson, Pascal H and Gaudriot, Baptiste and Provenchère, Sophie and Rozec, Bertrand and Cholley, Bernard and Mauriat, Philippe and Sénard, Marc and Fellahi, Jean-Luc and NAPaR (Nordic Aprotinin Patient Registry) Investigators, NAPaR (Nordic Aprotinin Patient Registry) Investigators},
  title = {Half-Dose versus Full Dose of Aprotinin in Cardiac Surgery: A Post-hoc Analysis of the Aprotinin European Registry},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf260}
}
Kostenlos starten →